INTRODUCTION
Studies on non-cancer mortality in the Japanese atomic bomb survivors have shown a statistically significant increase in non-cancer disease death rates with radiation dose, with increasing trends observed for diseases of the circulatory, digestive and respiratory systems (1, 2) . The data show statistically significant increases for heart disease but no direct evidence of radiation effects for doses less than about 0.5 Sv (3, 4) . Another study examined the risk of coronary heart disease after radiotherapy for peptic ulcer (5) . Part of the heart was in the irradiated tissue volume and received very high doses of 7.6-18.4 Gy, corresponding to volume-weighted cardiac doses ranging from 1.6 to 3.9 Gy. The authors concluded that disease risk increased with dose. Similarly, childhood exposure of the scalp for Tinea capitis has been shown to significantly elevate risk for adult carotid atherosclerosis (6) . The mean dose to the heart was not described, but it could have been either large, since one report of this exposed population estimated a mean dose to the brain of 1.5 Gy (7), or relatively small, since another report estimated a dose of 9 cGy to the thyroid (8) .
The position regarding occupational exposure is less clear. In one report, a strong positive and statistically significant association between radiation dose (mean dose ,30 mSv) and deaths from atherosclerotic heart disease, including coronary heart disease, was observed in a cohort of occupationally exposed workers (9) . Assuming that a positive correlation of excess risk of cardiovascular disease at low radiation doses existed, Little et al. (10) produced a mechanistic model where multiple small radiation doses cause the mean chemoattractant (MCP-1) concentration to increase linearly with cumulative dose, consistent with a linear relationship between risk and dose at low doses. However, a review of the epidemiological literature, other than the literature on atomic bomb survivors, did not provide clear evidence of an increased risk of circulatory diseases at doses of ionizing radiation in the range 0-4 Sv (11) . In contrast, other epidemiological evidence indicates that exposures to low-LET radiation ( dose rate, 2.80 mGy/year) protected workers (P , 0.05) generally from all diseases of the circulatory system [standard mortality ratio (SMR) 0.73-0.76] and specifically from arteriosclerotic heart disease (SMR 0.74-0.79) (12) . Similarly, the IARC 15-Country Study showed an approximately 35% deficit in cardiovascular disease at low occupational doses (20 mSv) but a 10% increase at higher doses (200 mSv), indicating a highly non-linear dose response (13) .
It is therefore unclear from the human data whether an association between heart disease and radiation exposure at low doses exists. If such an association is real, it is also unclear whether there is a general radiation-induced change in risk for the whole population or whether any change is associated with particular dietary circumstances, radiation quality or sensitive subgroups. For example, it is possible that the increased risk from radiation exposure occurs only in persons genetically predisposed to heart disease or is related to the mixed-LET nature of their exposure.
One approach to testing these possibilities is the use of animal models, and the effect of radiation exposure plus dietary circumstance has been tested by Tribble et al. (14) . They showed that high doses (2-8 Gy) of low-LET ionizing radiation given at high dose rate accelerated aortic lesion formation in normal C57BL/6 mice, but only if they were fed a high fat diet within 1-2 weeks after exposure. The increase in mean lesion area was a function of dose, but this effect was suppressed in mice overexpressing CuZn-SOD, suggesting a link to oxidative stress. Pakala et al. (15) found a similar increase in lesion size in hypercholesterolemic rabbits that had their iliac arteries exposed, but the doses used were very high (15 Gy). A similar study by Cottin et al. (16) also using a local 15-Gy aortic dose in hypercholesterolemic rabbits found increased plaque burden and more advanced plaque types.
Animals can also be used to model genetic susceptibility to heart disease. Apolipoprotein E acts as the main ligand mediating removal of cholesterol-enriched chylomicron and VLDL remnants. Mice that are deficient in the production of apoE are susceptible to atherosclerosis when fed a normal low fat diet, and the progression of the disease is further exacerbated when the mice are fed a diet enriched in fat and cholesterol. This sensitivity to atherosclerosis in ApoE 2/2 mice is due directly to the apoE deficiency, since apoE (derived from macrophages) reduced hypercholesterolemia in the apoE-deficient mice, leading to a decreased susceptibility to atherosclerosis (17) . Stewart et al. (18) also conducted a high-dose study of radiation-induced atherosclerosis and examined the carotid arteries (14 Gy neck exposure) of atherosclerosis-prone ApoE 2/2 mice fed a normal-fat diet. They showed that cholesterol levels in irradiated mice were not significantly different from those in age-matched controls and that markers of systemic inflammation were not elevated. However, compared to age-related atherosclerotic lesions, radiation accelerated the development of macrophage-rich, inflammatory atherosclerotic lesions prone to intraplaque hemorrhage. Hoving et al. (19) showed similar results in ApoE 2/2 mice exposed to high-dose fractionated (20 3 2 Gy) radiation. Schiller et al. (20) also conducted a high-dose study and compared aortic lesion formation in lethally irradiated (10 Gy) low-density lipoprotein receptor knockout mice (Ldlr
2/2
). The mice were rescued by reconstitution with bone marrow from syngeneic Ldlr 2/2 mice and fed a high-fat diet. Compared to non-reconstituted and nonirradiated mice, thoracic aorta lesion areas were smaller but aortic root lesion areas were greater in the transplanted mice than in non-transplanted mice.
While the high-dose data in animal models seem to be generally consistent with at least some of the high-dose human data, there are no animal data for the effects of low doses. Given the uncertainty regarding the ability of lower doses of low-LET radiation to promote atherosclerosis, we report here the results of an in vivo mouse study to test the hypothesis that low doses of ionizing radiation, in the range of 0.025-0.5 Gy, would promote the progression of atherosclerotic lesion formation in mice that are genetically predisposed to this disease (ApoE
). Because of the close link between this disease and circulating lipoprotein levels in this mouse model, we further tested the hypothesis that any radiationinduced change in the progression of atherosclerotic lesions was linked to associated changes in serum lipoprotein levels. We report measures of the effects of high-and low-dose-rate radiation on changes in lesion frequency, size and severity, along with general measures of total serum cholesterol levels as well as specific measures of the fraction of lesion lipid within associated macrophages.
METHODS

Mice
The ApoE 2/2 (B6.129P2-Apoe tm1lUnc /J) female mice were obtained at 4-6 weeks of age from Jackson Laboratory (Bar Harbor, ME). These mice are homozygous null for a functional ApoE gene (in a C57BL/6J background). They display marked atherosclerosis when fed a normal diet that is low in fat, and the lesions can be accelerated in both size and complexity if the mice are fed a diet enriched with fat. The morphological features of early-stage lesions in ApoE 2/2 (21-23) mice are very similar to those found in humans (24) (25) (26) . Mice of the same genetic background but wild-type for ApoE (ApoE z/z ) were obtained from the same supplier.
The mice were barrier-raised at Jackson Laboratory and then maintained as specific-pathogen-free mice at the Chalk River Laboratories. Health monitoring during and at the end of the study indicated no change in specific-pathogen-free status. Mice were group-housed, six per standard shoebox cage, in ventilated microisolators. They were provided with Bed-O-Cob bedding (Frisco Enterprises, Boulton, Ontario) and ad libitum reverse osmosis, UVlight-treated water and Charles River Rodent Chow no. 5075 (Charles
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River Canada, St. Constant, Quebec), which is a normal, low-fat (4.5%) diet. The mice were divided into groups and ear punched to identify them by group and as individuals within a cage. Mice were monitored daily for general health.
All housing, handling and experimental procedures were conducted in accordance with the guidelines of the Canadian Council on Animal Care and with the preapproval of the local AECL Animal Care Committee.
Irradiation
The unrestrained mice in their plastic cages were exposed beginning at either 7-8 weeks of age or 8 months of age to 60 Co c radiation at low dose rate from an open beam source (GammaBeam 150, Atomic Energy of Canada Limited) or exposed singly in a plastic container to 60 Co c irradiation at high dose rate in an enclosed irradiator (GammaCell 200, Atomic Energy of Canada Limited). The groups were exposed to either 0.025, 0.05. 0.10 or 0.50 Gy at either low dose rate (1.0 mGy/min, GammaBeam 150, Atomic Energy of Canada Limited) or high dose rate (about 0.15 Gy/ min, GammaCell 200, Atomic Energy of Canada Limited). Animals received their designated dose as a single exposure except those receiving 0.5 Gy at low dose rate, which received 100 mGy per day at 1 mGy/min for 5 consecutive days. Control (0 Gy) mice were handled and transported in the same manner as exposed mice and were placed in a shielded space beside the radiation source (and sharing the same atmosphere) during the exposure of the test group. After the treatments, the mice were monitored for general health once daily. Typically, samples from 8 animals were analyzed per dose at each dose rate and time of examination, except typically 6 animals were analyzed for the percentage of lipid within lesion macrophages, or as otherwise noted.
Study Termination/Timeline
Mice were exposed either at an early stage of disease (2 months of age) or at a late stage of disease (8 months of age). Mice exposed at an early stage of disease were euthanized and tissues were collected either 3 or 6 months after exposure (at 5 or 8 months of age). Mice exposed at a late of stage disease (8 months of age) were euthanized and tissues were collected 2 or 4 months after exposure (at 10 or 12 months of age).
Tissue/Blood Collection
Just prior to sampling of blood and tissue, the mice were euthanized with an intraperitoneal injection of sodium pentobarbital. Terminal blood samples were collected by puncture of the right ventricle. Blood was allowed to clot at room temperature for 30 min and then was centrifuged at 1000g for 25 min at 4uC. Serum samples were immediately tested for total cholesterol.
Serum Cholesterol
Individual serum total cholesterol concentrations were determined using a commercially available colorimetric assay (Wako Bioproducts, Richmond, VA), following a slight modification of the manufacturer's instructions to allow for quantification using a 96-well microtiter plate format. For this analysis, serum from ApoE z/z mice as well as from ApoE 2/2 mice was collected and measured.
Heart Tissue Collection
Mice were perfused with PBS via a cannula placed in the left ventricle, with perfusate drained from a severed right atrium. Hearts were separated from the aorta at the base, embedded in optimum cutting temperature (OCT) medium, and snap-frozen on a metal plate that was cooled with liquid nitrogen.
Quantification of Atherosclerotic Lesions in Tissue Sections
The size of atherosclerotic lesions in the ascending aorta was determined from five Sudan IV-stained serial sections from each mouse counterstained with Weigart's hematoxylin and cut 10 mm thick and separated by 100 mm. Lesion analysis began with the first section of tissue that contained the ostia for the coronary arteries, a region defining the boundary between the aortic sinus and ascending aorta. Using the staining as a guide, lesion area defined as intimal tissue within the internal elastic lamina was determined using ImagePro Plus software (V6.2, Media Cybernetics, Silver Springs, MD) on images that were created using a digital CoolSNAP cf camera (Roper Scientific Inc., Duluth, GA). The mean lesion cross-sectional area derived from the five serial sections was taken as the average lesion size for each animal as described previously (27) (28) (29) (30) (31) . We calculated the average number of lesions that could be counted within the five histological sections used per mouse to determine the mean lesion number in the control (0 Gy) and irradiated (0.025-0.5 Gy) mice.
Based on the staining patterns of lesions for neutral lipid (Sudan IV), each lesion identified in each of the five serial sections was classified as being at a stage of severity in the range 1-5. This process uses the human lesion classification format (32, 33) for being either in the early stages of severity (stages 1 to 3), consisting mainly of macrophage-derived foam cells, or in the advanced stages of severity (stages 4 and 5), which are characterized by a well-defined necrotic core either with or without a fibrous cap.
Quantification of the Percentage of Lesion-Associated Lipid within Macrophages
Histological analysis was performed as described previously (27, 31) using four sequential sections of the ascending aorta of each mouse to detect neutral lipid and macrophages. Sudan IV was used to stain for neutral lipid and immunohistochemistry was used to detect macrophages. For the latter, detection was achieved by first incubating tissue with rabbit antisera to mouse macrophages (1:5000 dilution, Accurate Chemical Co.) followed by a biotinylated secondary antibody against rabbit and finally incubation with avidinperoxidase (Vectastain Elite ABC kit, Vector Laboratories) for visualization of the positive staining. The lesion area staining positive for macrophages and for neutral lipid was quantified using ImagePro Plus. An imprint was made for each area and superimposed using Adobe Photoshop CS2 (Version 9.0.2). Both imprints were still distinguishable at this point; only the overlapping areas appeared darker. The superimposed image was then imported to ImagePro Plus to measure the amount of overlap, and the percentage of lipid associated within macrophages was calculated by dividing the overlapping area with the total area of lesion-associated lipid. It is important to note that each section used for the overlay of lesionassociated lipid and macrophage areas was separated by only 10 mm.
Statistics
Data for lesion severity (as measured by lesion stage) as well as for the mean cross-sectional areas (size) or numbers of lesions in the aortic roots, plus lipid in lesion macrophages of the exposed and unexposed groups of mice, and mean serum cholesterol values were tested for normal distribution and variance. When the data were normally distributed and had equal variance, comparisons of unexposed control animals with mice exposed to individual doses were made using a Student's t test. Data not normally distributed or with unequal variances were compared using the Mann-Whitney rank sum test. The t tests and Mann-Whitney rank sum tests were done with the statistical program SigmaStat 3.10 (Systat Software Inc., Point Richmond, CA). Two-tailed P values of #0.05 were considered significant.
In addition to the univariate tests of significance, global tests of significance of the modifying effects of dose rate and time were i 5 2, 3, 4) . The model with the optimal combination of knots is selected that yields the smallest value of Akaike information criteria (AIC), defined as 22ln L z 2p, where L is the likelihood for an estimated model with p parameters. For each end point, we stratified the data set by high or low dose rate and by 3 or 6 months postirradiation for early disease stages and by 2 and 4 months for late disease stages. Formal statistical tests for heterogeneity between these groups were conducted.
RESULTS
Unexposed ApoE
2/2 Mice Aortic atherosclerotic lesion frequency was initially low in young ApoE 2/2 mice (2 months of age) but increased rapidly with time in the unexposed animals ( Fig. 1A) , reaching a maximum at about 8 months of age. The average size of each lesion also increased with the age of the animals (by about 0.003 mm 2 /day) but did not show any indication of reaching a maximum within 12 months (Fig. 1B) . Similarly, average lesion severity continued to increase as the unexposed mice aged (Fig. 1C) . Between 2 and 8 months of age, lesion severity increased by an average of 1.68 stage units, or about 0.0093 stage units/day. Figure 1D shows the distribution of lesion stages of severity with increasing age. Most lesions were not severe (stage 1-2) in unexposed 2-month-old mice but progressed to more severe stages with time. At 8 months of age, most aortic lesions had reached stage 4, and by 10 months of age about half the lesions had reached the most severe level, stage 5. Animals wild-type for ApoE (ApoE z/z ) were also examined for aortic lesions. None were observed.
Total serum cholesterol increased slightly as the unexposed mice aged (Fig. 1E) and reached a maximum at about 10 months of age, which was significantly higher than at 2 months of age (P , 0.01). Animals wildtype for ApoE (ApoE
, open squares, Fig. 1E ) were also tested for total serum cholesterol at 5 and 8 months of age and had levels 6-to 7-fold lower than the ApoE 2/2 mice of the same age. Figure 1F shows, as a function of unexposed animal age, the percentage of total lesion lipid that was contained by macrophages that were within aortic atherosclerotic lesions. The figure shows that in young mice, at a time when atherosclerotic lesions are small and generally not severe (2 months of age), the majority of lesion lipid was contained within macrophages. This high percentage of lipid in lesion macrophages declined rapidly with time, and at 8 months of age, when most lesions (about 65%) were generally classified as severe (stage 4, Fig. 1D ), less than 10% of the total lesion lipid was contained within lesion macrophages. Fig. 1 ), ApoE 2/2 mice were exposed to low doses of radiation delivered at either low or high dose rate and then examined 3 or 6 months after exposure (at 5 and 8 months of age), times at which the disease had significantly advanced in unexposed mice (Fig. 1). a. Exposure at low dose rate Compared to unexposed controls (Fig. 1A) , low-dose exposure generally reduced lesion frequency ( Fig. 2A) , but the reduction was restricted to the lowest doses used. At one or the other of the lowest doses examined (25 or 50 mGy), radiation exposure reduced lesion frequency in animals examined 3 months after exposure, and this effect persisted until 6 months after exposure. This protective effect tended to be reduced or disappear when the dose increased above these doses.
Exposed ApoE
The effect of radiation on the average cross-sectional area of the lesions measured in the aortic root is shown in Fig. 2B . At 5 months of age, lesions were small in unexposed mice (Fig. 1B) , and at that time no significant effect of radiation on lesion area was seen. However, by 8 months of age, lesion size in unexposed mice had increased considerably (Fig. 1B) , and a significant radiation effect was then evident. The average lesion size for each group of animals receiving any dose between 0.025 to 0.5 Gy at low dose rate (Fig. 2B) was smaller than for the unexposed control mice. Again, 25 and 50 mGy were the most effective doses.
After the radiation exposures at 2 months of age, lesion severity was assessed as dose-dependent changes in average severity and as changes in lesion stage frequency. While the average lesion severity increased with mouse age between ages 5 months and 8 months in unexposed controls (Fig. 1C, D) , average lesion severity showed no additional statistically significant change with increasing dose, given at low dose rate, when measured at either 3 or 6 months after exposure (i.e. at 5 or 8 months of age). A similar conclusion was reached when the analysis was based on the relative frequency of lesions at each stage (data not shown).
Serum cholesterol was high in the unexposed ApoE
mice at all ages (Fig. 1E ). Exposure to any dose of radiation at low dose rate, up to 0.5 Gy, had no significant effect on the high level of total serum cholesterol measured either 3 or 6 months after exposure at an early stage of disease, i.e. 2 months of age (data not shown). Compared to unexposed control mice (Fig. 1F ), there were no statistically significant changes in the percentages of the lesion lipids that were contained in macrophages within the aortic lesions of the exposed mice when they were examined either 3 or 6 months after any dose at an early stage of disease (data not shown). 
b. Exposure at high dose rate
The effects on lesion frequency and size of low-dose exposures given at high dose rate (Fig. 3A, B) were qualitatively similar to the inhibitory effects observed after the same doses given at low dose rate ( Fig. 2A, B) . The high-dose-rate effects were also similar to the lowdose-rate effects when compared at different times after exposure. As observed after the low-dose-rate exposure, the lowest doses used (25-50 mGy) tended to be the most effective at reducing both lesion frequency and size.
While exposure at low dose rate had no significant effect on lesion severity, exposure at high dose rate produced a different result. Figure 3C shows the distribution of lesions within the five stages of severity and compares unexposed animals to animals that had received 0.025 Gy at high dose rate when examined 3 months after exposure, i.e. at 5 months of age. The exposure resulted in a significant decrease in lesions at the least severe stage 1, with a commensurate increase in lesions at stages 2 and 3. While about 40% of the lesions were at the more severe stage 4, the exposure had no effect on the severity of those lesions. This acceleration of early-stage lesion severity by 0.025 Gy lost statistical significance as the disease progressed with time when the animals were examined 6 months after exposure, i.e. at 8 months of age (data not shown). Exposure to higher doses at high dose rate had no significant effect (data not shown).
In contrast to the lack of effect of radiation given at low dose rate, every dose between 0.025 and 0.5 Gy given at high dose rate (Fig. 3D) significantly elevated the total serum cholesterol when the mice were examined 3 months after the exposure. When examined 6 months after the high-dose-rate exposures, a similar trend of increased serum cholesterol was observed, but the increases were statistically significant only for doses of 0.025 and 0.5 Gy.
Also in contrast to the lack of effect seen after a lowdose-rate exposure, when mice were exposed at high dose rate and examined 3 months later, a dose of 0.025 Gy produced a marginally nonsignificant decrease in the percentage of the lesion lipid contained within macrophages (P 5 0.07) that became a significant decrease at 0.05 Gy (Fig. 3E) . As the dose increased further, that result became not significantly different from controls. However, measurements taken 6 months after the high-dose-rate exposures suggested an opposite trend, with the mice exposed to 0.05 Gy or 0.5 Gy showing a significantly elevated percentage of lesion lipids contained within macrophages.
Exposure at late stage of disease
Mice were also exposed to doses between 0.025 and 0.5 Gy at high or low dose rate when the mice were 8 months of age. At that age the mice were at a late stage of disease and the lesions in the aortic root were near maximum numbers (Fig. 1A) and size (Fig. 1B) , and most lesions had progressed to stage 4, which is considered severe (Fig. 1D) . After radiation exposure, the mice were examined 2 or 4 months later when they were either 10 or 12 months of age, times at which further changes in the lesions of the unexposed mice were relatively smaller.
a. Exposure at low dose rate Exposure to 0.05 Gy at low dose rate had a small (10-14%) but statistically significant effect (Fig. 4A ) of increasing the lesion frequency when the mice were examined 2 months after exposure, i.e. at 10 months of age (compared to unexposed controls). Increasing the dose to 0.1 or 0.5 Gy resulted in marginally nonsignificant increases (P 5 0.06 and 0.07, respectively). When the mice were subsequently examined at 12 months of age, there was a trend to lower frequencies compared to the unexposed animals, but this was not statistically significant. This result suggested that some low doses given at low dose rate in a late stage of disease could have a small, transient influence on accelerating the appearance of aortic lesions.
Exposure to low doses at low dose rate significantly reduced average lesion size by about 30% for doses from 0.05 to 0.5 Gy when the mice were examined at 12 months of age, i.e. 4 months after exposure (Fig. 4B) . No significant effect was evident if the mice were examined earlier, at 10 months of age.
Low-dose-rate exposure of mice with late-stage disease to doses between 0.025 and 0.5 Gy resulted in a generally dose-dependent decrease in total serum cholesterol that was a nonstatistically significant trend 2 months after exposure but that became statistically significant when measured at 4 months after exposure. The decreases at each dose became larger with increased time after exposure (Fig. 4C) . The largest decrease was observed 4 months after exposure to 0.1 Gy, when the serum cholesterol levels were about 40% below those of RADIATION AND HEART DISEASE IN ApoE 2/2 MICE the unexposed animals ( Fig. 1E, P , 10 
25
). The levels in these mice exposed to 0.1 Gy were actually about 25% lower than the values observed in even the very young (2-month-old) unexposed mice (Fig. 1E) .
At 10 months of age, most lesions were at either stage 4 or stage 5 in unexposed mice (Fig. 1D) . A small inhibitory effect on the progression of lesion severity was seen when mice were exposed at low dose rate, but the slowing was significant only at 0.025 Gy (Fig. 5A ). This slowing of progression of stage 4 lesions to stage 5 lesions was no longer significant when the mice reached 12 months of age (data not shown).
b. Exposure at high dose rate
Exposure at a late stage of disease to any dose at high dose rate had no significant effect on lesion frequency or on average lesion size, regardless of the dose or time of examination (data not shown). Exposure to the same doses and dose rate likewise produced no significant changes in total serum cholesterol whether it was measured 2 or 4 months after exposure at 8 months of age. A high-dose-rate exposure of either 0.025 or 0.05 Gy given at a late stage of disease (at 8 months of age) significantly slowed, by about half, the fraction of lesions that had progressed in severity from stage 4 to stage 5 disease when examined at 10 months of age (Fig. 5B) . This slowing of the progression of the disease was temporary, since it was no longer significant when the mice reached 12 months of age (data not shown).
Groups of animals that were wild-type for ApoE (ApoE z/z ) were also exposed at 8 months of age to doses from 0.025 Gy to 0.5 Gy at low and high dose rates. The aortas were examined for lesions and total serum cholesterol was measured 3 and 6 months later. No lesions were observed and no significant changes from the cholesterol values measured in unexposed mice (Fig. 1E) were seen (data not shown).
Analysis of heterogeneity
We analyzed the data for heterogeneity. Analysis of aortic root data among mice aged 2 months at irradiation (early-stage disease) demonstrated statistically significant differences (P , 0.01) by dose rate overall and within the data taken 6 months after exposure. Likewise, for the mice exposed at 8 months of age (late-stage disease), there were statistically significant differences (P , 0.01) by dose rate overall (combining mice examined at 10 months and at 12 months) and by dose rate (P , 0.05) within the mice examined at 12 months but not within the mice examined at 10 months. Analysis of cholesterol data among mice aged 2 months at irradiation demonstrated statistically significant (P , 0.01) differences by dose rate overall and within the data taken 3 months after exposure. Analysis of lipid in macrophages among mice aged 2 months at irradiation indicated that there were statistically significant (P , 0.05) differences overall by dose rate.
DISCUSSION
In the experiments presented here, ApoE 2/2 mice were used to test the influence of exposure to low-LET radiation on atherosclerotic disease progression in a genetically predisposed group. In the absence of radiation exposure, the disease progressed rapidly, with lesion numbers and size reaching near maximum values by the time the mice were 8 months of age (Fig. 1A, B) . Similarly, by that age, most lesions had progressed to stage 4 of severity (Fig. 1C, D) . Because of their genetic deficiency, serum cholesterol was already high in young animals and also increased to a maximum between 8 and 10 months of age (Fig. 1E) . Conversely, the percentage of lesion lipid contained in lesion-associated macrophages dropped with age and reached a low level when the mice were 8 months old (Fig. 1F) .
Exposure of the ApoE 2/2 mice to doses between 0.025 and 0.5 Gy influenced many of the above-noted parameters of atherosclerosis, but the effects of the exposures varied with the dose, dose rate, time of measurement and stage of the disease when the mice received the radiation exposure. A summary of the effects on the measured end points (compared to unexposed controls) grouped by dose rate and disease state at exposure is given in Table 1 .
Exposure at Early Stage of Disease
In some experiments the ApoE 2/2 mice were exposed to a single low dose at 2 months of age, when the disease was at an early stage of development. At that age, existing lesions were few (Fig. 1A) and small (Fig. 1B) , and most had not yet progressed beyond a relatively mild stage 2 of severity (Fig. 1D) .
Exposure at either low or high dose rate induced a protective effect that slowed both the formation of new lesions (Figs. 2A, 3A ) and the increase in the size of existing lesions (Figs. 2B, 3B) . At both dose rates, maximum inhibition of lesion growth was produced by a dose of 25 or 50 mGy. However, while the low-dose-rate exposures had no influence on lesion severity, high-doserate exposure to 25 mGy significantly accelerated progression of the least severe stage 1 lesions to more severe stage 2 and 3 lesions when measured 3 months after the exposure, i.e. at 5 months of age (Fig. 3C) . The observed increase in lesion severity appeared to be linked to an influence of the high-dose-rate exposure on lesion lipid metabolism and lipid uptake by macrophages, since, also at 3 months after exposure, less lesion lipid appeared in lesion-associated macrophages (Fig. 3E) and more in the lesion itself. This impairment of lesion lipid uptake by macrophages was accompanied by a persistent increase in total serum cholesterol (Fig. 3D) to levels higher than those seen in the unexposed mice (Fig. 1E) . This result suggested that low doses given at (Fig. 3E) , the impairment in the ability to clear serum lipids persisted for up to 6 months after exposure (Fig. 3D ).
These observations indicate that while low doses given at either high or low dose rate at an early stage of disease can induce effects that protect against lesion formation and growth, there is a distinct dose-rate-dependent difference in the ability of low doses to influence and modulate lipid metabolism and affect lesion severity. Consequently, while low doses given at low dose rate induce only protective effects, the same doses given at high dose rate appear to induce both protective and detrimental effects ( Table 1) . The results therefore suggest that the influence of low doses on lesion formation and size may proceed by a mechanism that is independent of the effect of low doses on lipid metabolism and lesion severity. The results also indicate a potential long-term detrimental effect of high-doserate exposure at an early stage of disease, even when the doses are as low as 25 mGy.
Exposure at Late Stage of Disease
In some experiments, the ApoE 2/2 mice were exposed at 8 months of age, when the disease was in its later stages. At that age, lesion frequency and size were near maximum, and most lesions had reached a stage 4 level of severity (Fig. 1) . Again, exposure to low doses of radiation was at either high or low dose rate. The mice were examined 2 or 4 months later, i.e. at 10 or 12 months of age.
The effect of exposure of mice with late-stage disease to low doses at low dose rate generally produced protective effects, as was observed for low-dose-rate exposure at an early stage of disease (Table 1) . However, while lesion growth (Fig. 4B ) was retarded as in an early stage of disease, the protective effects at a late stage of disease also manifested as a reduction in serum cholesterol (Fig. 4C) and as a slowing in the progression of lesion severity (Fig. 5A) , neither of which were seen when the mice were exposed at an early stage of disease. If, as suggested by the results of exposures at an early stage of disease, modulation of lipid metabolism and macrophage uptake of lipids represents one mechanism by which low doses influence atherosclerosis, then the reduction in serum cholesterol by low doses given at a late stage of disease would seem consistent with the observed parallel slowing in the progression of lesion severity.
Again as suggested by the observations from exposures at an early stage of disease, there is a second mechanism by which low doses affect atherosclerosis, and that mechanism influences both new lesion formation and the growth of those lesions. While low-dose, low-dose-rate exposures given at an early stage of disease slowed advancement of both those end points, the same doses given at a late stage of disease also slowed the growth of lesions but appeared to temporarily accelerate the formation of new lesions (Fig. 4A) . That temporary increase in lesion frequency appears to be inconsistent with the generally protective effects seen, and this observation could suggest that the influence of low doses on these two end points proceeds by different mechanisms. However, we hypothesize that this observation may be an analysis artifact resulting from the other observed effects. Since the exposures slowed both the growth and the progression of the lesions to more severe disease, the lesions may have been relatively smaller, potentially making it easier to distinguish separate lesions at this late stage of lesion development and consequently resulting in an apparent increase in frequency.
The effects on changes in lesion severity of low doses given at high dose rate when the mice had late-stage disease were strongly protective against increases in lesion severity (Fig. 5B ) and opposite to those seen on lesion severity for early-stage disease (Fig. 3C) . This result suggests that some of the effects of low-dose radiation on atherosclerosis depend on the state of progression on the disease and that exposures at an early or late stage should be considered separately. They also suggest that low-dose exposures may influence this disease by a third mechanism, which is protective and specific for late-stage disease.
CONCLUSIONS
To date, the effects of low doses on atherosclerosis have not been studied in animal models. The data presented here clearly show that single doses of 25-500 mGy, given at either an early or late stage of disease, can have a significant impact on the development of atherosclerosis in mice fed a normal diet low in fat but genetically predisposed to the disease (ApoE
2/2
). The effects of the single doses often persisted for months, but some were ultimately transient in nature. All effects were distinctly non-linear with dose and were generally protective for low-dose-rate exposures given at either an early or late stage of disease. However, high-dose-rate exposures given at an early stage of disease development showed both protective and detrimental effects, indicating that multiple mechanisms may influence the outcome. Most effects occurred below about 100 mGy, and many of the end points measured showed maximum effects at 25-50 mGy, the lowest doses used here, indicating that even lower doses need to be examined.
The results of these animal studies have implications for human health. Many human epidemiological studies have shown the detrimental effects of high-dose exposure for a variety of cardiovascular or circulatory diseases. However, most such studies have either failed to show statistically significant increased risk at doses below about 0.5 Gy (3, 4, 11, 34) or have shown protective effects at doses similar to those used in this mouse study (12, 13) . The highly non-linear dose response evident in the disease progression data shown here very much resembles the non-linear (protective then detrimental) cardiovascular mortality seen with similar increasing low doses in one human study (13) , suggesting that the animal responses are paralleling the human response. This parallel exists in spite of the fact that these mouse studies measured markers of disease progression rather than the risk of lethality, as usually reported in human studies. It needs to be recognized, however, that this study deals with single exposures. The effects of multiple or chronic low-dose exposures, such as modeled by Little et al. (10) , remain to be determined.
